Alendronate liposomes for antitumor therapy: Activation of γδ T cells and inhibition of tumor growth

Advances in Experimental Medicine and Biology

Volumn 733, Issue , 2011, Pages 165-179

  Gutman, Dikla ^a   Epstein Barash, Hila ^a   Tsuriel, Moshe ^a   Golomb, Gershon ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Liposome; Monocyte; nBP; TAM; T cells

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; LIPOSOME; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER INHIBITION; CD3+ T LYMPHOCYTE; CELL INTERACTION; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG ACCUMULATION; DRUG EXTRAVASATION; ENCAPSULATION; FEMALE; GAMMA DELTA T LYMPHOCYTE; HUMAN; HUMAN CELL; LIPOSOMAL DELIVERY; MOLECULARLY TARGETED THERAPY; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TARGET CELL; TUMOR ASSOCIATED LEUKOCYTE; ARTICLE; DOSE RESPONSE; DRUG EFFECT; DRUG POTENCY; ENDOCYTOSIS; EX VIVO STUDY; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MONOCYTE; TUMOR LOCALIZATION; VALIDATION PROCESS;

ALENDRONATE; ANALYSIS OF VARIANCE; ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; LIPOSOMES; LYMPHOCYTE ACTIVATION; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, NUDE; MONOCYTES; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTE SUBSETS; TUMOR NECROSIS FACTOR-ALPHA; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84934442719     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-94-7-2555-3_16     Document Type: Conference Paper

References (60)

1. Adami, S., Bhalla, A. K., Dorizzi, R., Montesanti, F., Rosini, S., Salvagno, G., & Locascio, V. (1987). The acute-phase response after bisphosphonate administration. Calcifi ed Tissue International, 41, 326-331.
2. Afergan, E., Epstein, H., Dahan, R., Koroukhov, N., Rohekar, K., Danenberg, H. D., & Golomb, G. (2008). Delivery of serotonin to the brain by monocytes following phagocytosis of liposomes. Journal of Controlled Release, 132, 84-90.
3. Allen, T. M., & Hansen, C. (1991). Pharmacokinetics of stealth versus conventional liposomes: Effect of dose. Biochimica et Biophysica Acta, 1068, 133-141.
4. Banciu, M., Schiffelers, R. M., & Storm, G. (2008). Investigation into the role of tumor-associated macrophages in the antitumor activity of Doxil. Pharmaceutical Research, 25, 1948-1955.
5. Bartlett, G. R. (1959). Phosphorus assay in column chromatography. The Journal of Biological Chemistry, 234, 466-468.
6. Cabillic, F., Toutirais, O., Lavoue, V., de la Pintiere, C. T., Daniel, P., Rioux-Leclerc, N., Turlin, B., Monkkonen, H., Monkkonen, J., Boudjema, K., Catros, V., & Bouet-Toussaint, F. (2010). Aminobisphosphonate-pretreated dendritic cells trigger successful V gamma 9 V delta 2 T cell amplifi cation for immunotherapy in advanced cancer patients. Cancer Immunology, Immunotherapy, 59, 1611-1619.
7. Caccamo, N., Meraviglia, S., Cicero, G., Gulotta, G., Moschella, F., Cordova, A., Gulotta, E., Salerno, A., & Dieli, F. (2008). Aminobisphosphonates as new weapons for gamma delta T cell-based immunotherapy of cancer. Current Medicinal Chemistry, 15, 1147-1153. (Pubitemid 351997804)
8. Caraglia, M., Marra, M., Naviglio, S., Botti, G., Addeo, R., & Abbruzzese, A. (2010). Zoledronic acid: An unending tale for an antiresorptive agent. Expert Opinion on Pharmacotherapy, 11, 141-154.
9. Clezardin, P. (2010). Bisphosphonates' antitumor activity: An unravelled side of a multifaceted drug class. Bone, 48, 71-79.
10. Clezardin, P., & Massaia, M. (2010). Nitrogen-containing bisphosphonates and cancer immunotherapy. Current Pharmaceutical Design, 16, 3007-3014.
11. Cui, Y. C., Kang, L., Cui, L. X., & He, W. (2009). Human gamma delta T cell recognition of lipid A is predominately presented by CD1b or CD1c on dendritic cells. Biology Direct, 4, 47.
12. Danenberg, H. D., Fishbein, I., Gao, J., Monkkonen, J., Reich, R., Gati, I., Moerman, E., & Golomb, G. (2002). Macrophage depletion by clodronate-containing liposomes reduces neointimal formation after balloon injury in rats and rabbits. Circulation, 106, 599-605. (Pubitemid 34827711)
13. Danenberg, H. D., Fishbein, I., Epstein, H., Waltenberger, J., Moerman, E., Monkkonen, J., Gao, J., Gathi, I., Reichi, R., & Golomb, G. (2003a). Systemic depletion of macrophages by liposomal bisphosphonates reduces neointimal formation following balloon-injury in the rat carotid artery. Journal of Cardiovascular Pharmacology, 42, 671-679. (Pubitemid 37305987)
14. Danenberg, H. D., Golomb, G., Groothuis, A., Gao, J., Epstein, H., Swaminathan, R. V., Seifert, P., & Edelman, E. R. (2003b). Liposomal alendronate inhibits systemic innate immunity and reduces in-stent neointimal hyperplasia in rabbits. Circulation, 108, 2798-2804. (Pubitemid 37498983)
15. Devilder, M. C., Maillet, S., Bouyge-Moreau, I., Donnadieu, E., Bonneville, M., & Scotet, E. (2006). Potentiation of antigen-stimulated V gamma 9 V delta 2 T cell cytokine production by immature dendritic cells (DC) and recpirocal effect on DC maturation. The Journal of Immunology, 176, 1386-1393. (Pubitemid 43134280)
16. Dieli, F., Vermijlen, D., Fulfaro, F., Caccamo, N., Meraviglia, S., Cicero, G., Roberts, A., Buccheri, S., D'Asaro, M., Gebbia, N., Salerno, A., Eberl, M., & Hayday, A. C. (2007). Targeting human gamma delta T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer. Cancer Research, 67, 7450-7457. (Pubitemid 47206575)
17. Eberl, M., Roberts, G. W., Meuter, S., Williams, J. D., Topley, N., & Moser, B. (2009). A rapid crosstalk of human gammadelta T cells and monocytes drives the acute infl ammation in bacterial infections. PLoS Pathogens, 5, e1000308.
18. Epstein, H., Berger, V., Levi, I., Eisenberg, G., Koroukhov, N., Gao, J., & Golomb, G. (2007). Nanosuspensions of alendronate with gallium or gadolinium attenuate neointimal hyperplasia in rats. Journal of Controlled Release, 117, 322-332. (Pubitemid 46216576)
19. Epstein, H., Gutman, D., Cohen-Sela, E., Haber, E., Elmalak, O., Koroukhov, N., Danenberg, H., & Golomb, G. (2008). Preparation of alendronate liposomes for enhanced stability and bioactivity: In vitro and in vivo characterization. AAPSJ, 10, 505-515.
20. Epstein-Barash, H., Gutman, D., Markovsky, E., Mishan-Eisenberg, G., Koroukhov, N., Szebeni, J., & Golomb, G. (2010). Physicochemical parameters affecting liposomal bisphosphonates bioactivity for restenosis therapy: Internalization, cell inhibition, activation of cytokines and complement, and mechanism of cell death. Journal of Controlled Release, 146, 182-195.
21. Ferrarini, M., Ferrero, E., Dagna, L., Poggi, A., & Zocchi, M. R. (2002). Human gamma delta T cells: A nonredundant system in the immune-surveillance against cancer. Trends in Immunology, 23, 14-18. (Pubitemid 34098956)
22. Fleisch, H. (1998). Bisphosphonates: Mechanisms of action. Endocrine Reviews, 19, 80-100. (Pubitemid 29122075)
23. Geran, R. I., Schumach, A. M., Abbott, B. J., Greenber, N. H., & Macdonal, M. M. (1972). Protocols for screening chemical agents and natural-products against animal tumors and other biological-systems. Cancer Chemotherapy Reports. Part 3, 3, 1-103.
24. Gnant, M., Mlineritsch, B., Schippinger, W., Luschin-Ebengreuth, G., Postlberger, S., Menzel, C., Jakesz, R., Seifert, M., Hubalek, M., Bjelic-Radisic, V., Samonigg, H., Tausch, C., Eidtmann, H., Steger, G., Kwasny, W., Dubsky, P., Fridrik, M., Fitzal, F., Stierer, M., Rucklinger, E., & Greil, R. (2009). Endocrine therapy plus zoledronic acid in premenopausal breast cancer. The New England Journal of Medicine, 360, 679-691.
25. Haber, E., Danenberg, H. D., Koroukhov, N., Ron-El, R., Golomb, G., & Schachter, M. (2009). Peritoneal macrophage depletion by liposomal bisphosphonate attenuates endometriosis in the rat model. Human Reproduction, 24, 398-407.
26. Haber, E., Afergan, E., Epstein, H., Gutman, D., Koroukhov, N., Ben-David, M., Schachter, M., & Golomb, G. (2010). Route of administration-dependent anti-infl ammatory effect of liposomal alendronate. Journal of Controlled Release, 148, 226-233.
27. Hava, D. L., Brigl, M., van den Elzen, P., Zajonc, D. M., Wilson, I. A., & Brenner, M. B. (2005). CD1 assembly and the formation of CD1-antigen complexes. Current Opinion in Immunology, 17, 88-94. (Pubitemid 40094019)
28. Hayday, A. C. (2000). Gamma delta cells: A right time and a right place for a conserved third way of protection. Annual Review of Immunology, 18, 975-1026. (Pubitemid 30365402)
29. Hewitt, R. E., Lissina, A., Green, A. E., Slay, E. S., Price, D. A., & Sewell, A. K. (2005). The bisphosphonate acute phase response: Rapid and copious production of proinfl ammatory cytokines by peripheral blood gd T cells in response to aminobisphosphonates is inhibited by statins. Clinical and Experimental Immunology, 139, 101-111. (Pubitemid 40066134)
30. Hinz, T., Wesch, D., Halary, F., Marx, S., Choudhary, A., Arden, B., Janssen, O., Bonneville, M., & Kabelitz, D. (1997). Identifi cation of the complete expressed human TCR V gamma repertoire by flow cytometry. International Immunology, 9, 1065-1072. (Pubitemid 27361749)
31. Hiraoka, K., Zenmyo, M., Watari, K., Iguchi, H., Fotovati, A., Kimura, Y. N., Hosoi, F., Shoda, T., Nagata, K., Osada, H., Ono, M., & Kuwano, M. (2008). Inhibition of bone and muscle metastases of lung cancer cells by a decrease in the number of monocytes/macrophages. Cancer Science, 99, 1595-1602.
32. Kirpotin, D. B., Drummond, D. C., Shao, Y., Shalaby, M. R., Hong, K. L., Nielsen, U. B., Marks, J. D., Benz, C. C., & Park, J. W. (2006). Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. Cancer Research, 66, 6732-6740. (Pubitemid 44085631)
33. Kunzmann, V., Bauer, E., Feurle, J., Weissinger, F., Tony, H. P., & Wilhelm, M. (2000). Stimulation of gamma delta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma. Blood, 96, 384-392. (Pubitemid 30463353)
34. Lang, J. K. (1990). Quantitative-determination of cholesterol in liposome drug products and raw-materials by highperformance liquid-chromatography. Journal of Chromatography, 507, 157-163. (Pubitemid 20155958)
35. Lewis, C. E., & Pollard, J. W. (2006). Distinct role of macrophages in different tumor microenvironments. Cancer Research, 66, 605-612. (Pubitemid 43165918)
36. Li, J. Q., Herold, M. J., Kimmel, B., Muller, I., Rincon-Orozco, B., Kunzmann, V., & Herrmann, T. (2009). Reduced expression of the mevalonate pathway enzyme farnesyl pyrophosphate synthase unveils recognition of tumor cells by V gamma 9 V delta 2 T cells. The Journal of Immunology, 182, 8118-8124.
37. Makkonen, N., Salminen, A., Rogers, M. J., Frith, J. C., Urtti, A., Azhayeva, E., & Monkkonen, J. (1999). Contrasting effects of alendronate and clodronate on RAW 264 macrophages: The role of a bisphosphonate metabolite. European Journal of Pharmaceutical Sciences, 8, 109-118. (Pubitemid 29189156)
38. Mariani, S., Muraro, M., Pantaleoni, F., Fiore, F., Nuschak, B., Peola, S., Foglietta, M., Palumbo, A., Coscia, M., Castella, B., Bruno, B., Bertieri, R., Boano, L., Boccadoro, M., & Massaia, M. (2005). Effector gamma delta T cells and tumor cells as immune targets of zoledronic acid in multiple myeloma. Leukemia, 19, 664-670. (Pubitemid 40521173)
39. Mayer, L. D., Bally, M. B., Cullis, P. R., Wilson, S. L., & Emerman, J. T. (1990). Comparison of free and liposome encapsulated doxorubicin tumor drug uptake and antitumor effi cacy in the SC115 murine mammary-tumor. Cancer Letters, 53, 183-190. (Pubitemid 20323611)
40. Miyagawa, F., Tanaka, Y., Yamashita, S., & Minato, N. (2001). Essential requirement of antigen presentation by monocyte lineage cells for the activation of primary human gamma delta T cells by aminobisphosphonate antigen. The Journal of Immunology, 166, 5508-5514. (Pubitemid 32374172)
41. Monkkonen, J., & Heath, T. D. (1993). The effects of liposome-encapsulated and free clodronate on the growth of macrophage-like cells in vitro: The role of calcium and iron. Calcifi ed Tissue International, 53, 139-146. (Pubitemid 23215390)
42. Monkkonen, J., Taskinen, M., Auriola, S. O., & Urtti, A. (1994). Growth inhibition of macrophage-like and other cell types by liposome-encapsulated, calcium-bound, and free bisphosphonates in vitro. Journal of Drug Targeting, 2, 299-308. (Pubitemid 24351010)
43. Patel, H. M. (1992). Serum opsonins and liposomes: Their interaction and opsonophagocytosis. Critical Reviews in Therapeutic Drug Carrier Systems, 9, 39-90.
44. Patel, H. M., & Moghimi, S. M. (1998). Serum-mediated recognition of liposomes by phagocytic cells of the reticuloendothelial system - the concept of tissue specifi city. Advanced Drug Delivery Reviews, 32, 45-60. (Pubitemid 28277175)
45. Richards, P. J., Williams, B. D., & Williams, A. S. (2001). Suppression of chronic streptococcal cell wall-induced arthritis in Lewis rats by liposomal clodronate. Rheumatology, 40, 978-987.
46. Rodan, G. A. (1998a). Control of bone formation and resorption: Biological and clinical perspective. Journal of Cellular Biochemistry. Supplement, 30-31, 55-61. (Pubitemid 29028726)
47. Rodan, G. A. (1998b). Mechanisms of action of bisphosphonates. Annual Review of Pharmacology and Toxicology, 38, 375-388. (Pubitemid 28231500)
48. Rodrigueza, W. V., Pritchard, P. H., & Hope, M. J. (1993). The infl uence of size and composition on the cholesterol mobilizing properties of liposomes in vivo. Biochimica et Biophysica Acta, 1153, 9-19. (Pubitemid 23348978)
49. Roelofs, A. J., Jauhiainen, M., Monkkonen, H., Rogers, M. J., Monkkonen, J., & Thompson, K. (2009). Peripheral blood monocytes are responsible for gamma delta T cell activation induced by zoledronic acid through accumulation of IPP/DMAPP. British Journal of Haematology, 144, 245-250.
50. Sela, E., Chorny, M., Gutman, D., Komemi, S., Koroukhov, N., & Golomb, G. (2010). Characterization of monocytestargeted nanocarriers biodistribution in leukocytes in ex-vivo and in-vivo models. Nano Biomedicine and Engineering, 2, 1-10.
51. Shmeeda, H., Amitay, Y., Gorin, J., Tzemach, D., Mak, L., Ogorka, J., Kumar, S., Zhang, J. A., & Gabizon, A. (2010). Delivery of zoledronic acid encapsulated in folate-targeted liposome results in potent in vitro cytotoxic activity on tumor cells. Journal of Controlled Release, 146, 76-83.
52. Slegers, T., van Rooijen, N., van Rij, G., & van der Gaag, R. (2000). Delayed graft rejection in pre-vascularised corneas after subconjunctival injection of clodronate liposomes. Current Eye Research, 20, 322-324. (Pubitemid 30428162)
53. Takahara, M., Miyai, M., Tomiyama, M., Mutou, M., Nicol, A. J., & Nieda, M. (2008). Copulsing tumor antigen-pulsed dendritic cells with zoledronate effi ciently enhance the expansion of tumor antigen-specifi c CD8+ T cells via V gamma 9 gamma delta T cell activation. Journal of Leukocyte Biology, 83, 742-754. (Pubitemid 351966884)
54. Torchilin, V. P. (2005). Recent advances with liposomes as pharmaceutical carriers. Nature Reviews. Drug Discovery, 4, 145-160. (Pubitemid 40282557)
55. van Rooijen, N., & Van Kesteren-Hendrikx, E. (2003). "In vivo" depletion of macrophages by liposome-mediated " suicide". Methods in Enzymology, 373, 3-16. (Pubitemid 41103273)
56. Veltman, J. D., Lambers, M. E. H., van Nimwegen, M., Hendriks, R. W., Hoogsteden, H. C., Hegmans, J., & Aerts, J. (2010). Zoledronic acid impairs myeloid differentiation to tumour-associated macrophages in mesothelioma. British Journal of Cancer, 103, 629-641.
57. Wilhelm, M., Kunzmann, V., Eckstein, S., Reimer, P., Weissinger, F., Ruediger, T., & Tony, H. P. (2003). Gamma delta T cells for immune therapy of patients with lymphoid malignancies. Blood, 102, 200-206. (Pubitemid 36759655)
58. Zeisberger, S. M., Odermatt, B., Marty, C., Zehnder-Fjallman, A. H., Ballmer-Hofer, K., & Schwendener, R. A. (2006). Clodronate-liposome-mediated depletion of tumour-associated macrophages: A new and highly effective antiangiogenic therapy approach. British Journal of Cancer, 95, 272-281. (Pubitemid 44187587)
59. Zhang, Y. H., Cao, R., Yin, F. L., Lin, F. Y., Wang, H., Krysiak, K., No, J. H., Mukkamala, D., Houlihan, K., Li, J. K., Morita, C. T., & Oldfi eld, E. (2010). Lipophilic Pyridinium Bisphosphonates: Potent gamma delta T Cell Stimulators. Angewandte Chemie-International Edition, 49, 1136-1138.
60. Zito, M. A., Koennecke, L. A., McAuliffe, M. J., McNally, B., van Rooijen, N., & Heyes, M. P. (2001). Depletion of systemic macrophages by liposome-encapsulated clodronate attenuates striatal macrophage invasion and neurodegeneration following local endotoxin infusion in gerbils. Brain Research, 892, 13-26. (Pubitemid 32126563)